or Try an Advanced Search...

    Specialty Drugs Stocks List

    Symbol Grade Name % Change
    BHC F Bausch Health Companies Inc. 0.19
    BIIB D Biogen Idec Inc. 0.59
    CVS F CVS Caremark Corporation 0.44
    CUE D Cue Biopharma, Inc. 1.86
    DCTH B Delcath Systems, Inc. 2.02
    EIGR F Eiger BioPharmaceuticals, Inc. 0.00
    FNCH F Finch Therapeutics Group, Inc. 0.40
    INZY D Inozyme Pharma, Inc. 1.61
    OPCH F Option Care Health, Inc. -1.30
    ORIC D Oric Pharmaceuticals, Inc. 1.58
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
    Related Stock Lists: Biotechnology Biopharmaceutical Life Sciences Medicine Pharmacy Autoimmune Disorders Cancer Chemotherapy Clinical Medicine Colitis Diarrhea Disease Immune Disorders Oncology Psoriasis S&P 500 Ulcerative Colitis Abdominal Pain Acne Actinic Keratosis

    Related ETFs - A few ETFs which own one or more of the above listed Specialty Drugs stocks.

    Symbol Grade Name Weight
    BIS C ProShares UltraShort Nasdaq Biotechnology 6.12
    IHF D iShares U.S. Health Care Providers ETF 5.06
    PBE C PowerShares Dynamic Biotech & Genome 4.61
    CFCV B ClearBridge Focus Value ETF 4.41
    DIP A BTD Capital Fund 4.41
    View all Specialty Drugs ETFs...
    Compare ETFs
    Compare BIS to CFCV Compare BIS to PBE Compare PBE to CFCV

        Specialty Drugs Stocks Recent News

        Date Stock Title
        May 3 CVS CVS Health Corporation Just Missed Earnings - But Analysts Have Updated Their Models
        May 2 CVS Analysts revise CVS stock targets after Aetna Medicare Advantage earnings plunge
        May 2 BHC Why Bausch Health Companies Stock Dived by More Than 7% Today
        May 2 BHC Bausch Health Companies (BHC) Q1 2024 Earnings Call Transcript
        May 2 CVS CVS Health Corporation (NYSE:CVS) Q1 2024 Earnings Call Transcript
        May 2 CVS CVS Health Stock: Free-Falling After Major Earnings Miss, Blame Game Begins
        May 2 CVS CVS Health cut to Neutral at UBS on Q1 miss
        May 2 BHC Bausch Health Companies Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 BHC Bausch Health Companies Inc Reports Q1 2024 Earnings: A Detailed Analysis Compared to Analyst ...
        May 2 BHC Bausch Health (BHC) Q1 Earnings and Revenues Miss Estimates
        May 2 BIIB Biogen Reports Progress on Corporate Responsibility Priorities
        May 2 CVS CVS Health First Quarter 2024 Earnings: EPS Misses Expectations
        May 2 BHC Bausch Health Companies GAAP EPS of -$0.17, revenue of $2.15B
        May 2 CVS Why Markets Must Beware Powell’s Comments on Fed Rate Hikes, and 5 Other Things to Know Today
        May 2 BHC Bausch Health Announces First Quarter 2024 Results
        May 2 CVS UPDATE 2-Cigna lifts annual profit view on lower medical costs, pharmacy benefit strength
        May 2 CVS Company News for May 2, 2024
        May 2 CVS CVS Health Corp (CVS) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...
        May 2 CVS Q1 2024 CVS Health Corp Earnings Call
        May 1 CVS Wall Street Lunch: 'No Stag, No Flation'
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
        Related Stock Lists: Biotechnology Biopharmaceutical Life Sciences Medicine Pharmacy Autoimmune Disorders Cancer Chemotherapy Clinical Medicine Colitis Diarrhea Disease Immune Disorders Oncology Psoriasis S&P 500 Ulcerative Colitis Abdominal Pain Acne Actinic Keratosis
        Specialty Drugs

        Specialty drugs are medications that are used to treat complex and chronic conditions, such as cancer, multiple sclerosis, and rheumatoid arthritis. They are typically more expensive than traditional medications and require special handling, storage, and administration. Specialty drugs may also require special monitoring and close follow-up with a healthcare provider.

        Browse All Tags